Encompass Health Q4 2022 Earnings Report
Key Takeaways
Encompass Health Corporation reported its Q4 2022 results, with discharge growth of 7.3% and double-digit earnings growth. The company's full-year results reached the top end of its guidance range. Encompass Health issued full-year 2023 guidance.
Net operating revenue growth of 9.1% resulted from volume growth and pricing increases.
Total discharge growth for the fourth quarter of 2022 was 7.3% with same-store growth of 4.2%.
The increase in cash flows provided by operating activities of 39.1% primarily resulted from higher income from continuing operations attributable to Encompass Health and lower tax payments.
The increase in Adjusted EBITDA of 16.4% primarily resulted from revenue growth and lower contract labor and sign-on and shift bonuses.
Encompass Health
Encompass Health
Forward Guidance
The Company provided the following guidance for full-year 2023.Net operating revenue $4,680 to $4,760 (in millions). Adjusted EBITDA $860 to $900 (in millions). Adjusted earnings per share from continuing operations attributable to Encompass Health $2.87 to $3.16